India BSE NSE Trading Suspension Orders — March 15, 2026

Board meeting April 22-23, 2026, to approve FY26 audited results under INDAS/IFRS, high materiality 9/10 indicating market-moving event

Potential final dividend recommendation post-results, signaling capital allocation priority to shareholders

Investor/analyst calls scheduled April 23, 2026, for business outlook discussion, opportunity for positive guidance refresh

Full compliance with SEBI insider trading regulations demonstrates robust governance, reducing regulatory overhang

Trading window closure March 16-April 27, 2026, standard for earnings, prevents premature insider selling on positive news

Dual reporting under INDAS and IFRS enhances transparency for global investors, supporting valuation premiums

Neutral sentiment with no bearish flags in filing, positioning for potential earnings outperformance vs IT peers

No insider pledges or sales noted pre-window closure, implying stable management holdings

Trading window closure amid FY26 results period may mask underlying strength until April 27 reopen

High materiality 9/10 vs typical announcements suggests above-average stock reaction potential

Absence of forward guidance cuts or negative sentiment in filing supports status quo valuation [NEUTRAL but leaning BULLISH]

Scheduled events cluster (board + calls) compresses catalysts, enabling quick market repricing

Audited Q4/FY26 results pending approval April 22-23, potential for misses vs market expectations with no pre-announced trends

Final dividend 'if any' recommendation, risk of omission or cut vs prior years amid no YoY capital allocation data

Trading window closed March 16-April 27, 2026, blocks visibility into management conviction via buys/sells

April 23 calls to discuss business outlook, risk of weak FY27 targets or margin pressure in competitive IT space

SEBI-mandated window closure highlights unpublished price-sensitive info period, amplifying pre-results volatility

Lack of disclosed YoY/QoQ financial ratios or operational metrics raises uncertainty on growth/margin trajectory

Filing sentiment neutral despite 9/10 materiality, potential for downside surprise if results underwhelm

Reopen April 27 could see selling if results disappoint, with no insider activity buffer

No details on buybacks/splits, risk of reinvestment over returns if dividend skipped

Board meeting April 22-23 at risk of postponement, delaying catalyst resolution

Accumulate ahead of April 22-23 board for potential beat, high 9/10 materiality implies strong repricing

Anticipate final dividend addition post-results, boosting total returns vs IT sector average

Tune into April 23 investor calls for FY27 guidance upgrades, historical IT outperformance pattern

SEBI compliance and transparency position Infosys as safe haven in regulatory-focused stream

Buy dip opportunity April 27, 2026, window reopen if results positive, limited insider selling risk

INDAS/IFRS dual results enable relative valuation vs global peers, potential multiple expansion

High materiality with neutral sentiment offers asymmetry for positive surprise trades

Compressed April 22-27 timeline allows quick alpha capture from results + outlook + reopen

No pre-closure sales signal stability, watch post-April 27 buys for conviction confirmation

As bellwether, positive Infosys results could lift peers, portfolio beta play

1/1 filings show standard board approvals for Q4/FY results (April 22-23), implying synchronized IT reporting season kickoff with high materiality [IMPLICATION: Sector volatility peak in late April]

Routine SEBI-compliant closures (March 16-April 27) across announcements, no unusual suspensions/delistings flagged [IMPLICATION: Limits short-term alpha but ensures fair disclosure]

Potential final payouts 'if any' in IT filings, no YoY trends but signals maturing shareholder returns focus [IMPLICATION: Yield chase opportunities post-results]

Investor calls (April 23) for business outlooks post-results, neutral sentiment baseline [IMPLICATION: Watch for FY27 targets to gauge sector growth]

Full adherence to SEBI insider regs in 1/1 cases, no pledges/holdings red flags [IMPLICATION: Reduces delisting risks in monitored stream]

Clustered events (board, calls, window reopen) in single filing, high 9/10 materiality [IMPLICATION: Time-sensitive trades around April 22-27]

Monitor approval of Q4/FY26 audited results and dividend rec, potential guidance hints; April 22-23, 2026

Track business outlook discussion for FY27 targets, margin/ growth updates; April 23, 2026

Watch reopen for insider transactions (buys/sells/pledges) signaling conviction; April 27, 2026

Post-board record date and payout details, vs historical yields; post-April 23, 2026

YoY/QoQ trends in revenue, margins, ROE once released, vs IT peers; April 23, 2026 release expected

Any insider activity or pledges post-window, compliance updates; ongoing from April 27

Capacity/volumes/costs in earnings, forward capacity guidance; April 23 calls

Scan for deal announcements tied to results, valuation/terms; April 22-23 board